loss medicines play a role in healthy ageing?

Emerging research suggests that weight-loss drugs like Ozempic and Wegovy may offer benefits beyond obesity treatment, potentially slowing biological aging. Studies show improvements in biological-age markers for some patients.
Why it matters
If confirmed, these findings could revolutionize the medical approach to aging and the long-term utility of GLP-1 receptor agonists.
THE search for a longer, healthier life may have taken an unexpected turn, with popular weight-loss medications emerging as potential weapons against the biological processes associated with ageing.
Drugs such as Ozempic and Wegovy, already attracting worldwide attention for their effectiveness in treating type 2 diabetes and obesity, are now being investigated for benefits that could extend well beyond the bathroom scales.
Emerging research suggests some patients taking the medications may experience improvements in biological-age measurements equivalent to turning back the clock by two to three years.
While scientists are far from declaring the discovery a breakthrough in reversing ageing, the findings have sparked considerable interest in the potential for these treatments to support healthier lives as people grow older.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in